IL1B and lung cancer: Using the Lewis lung cancer model, we found that the injection of L-MPs (Lewis) into the tumors resulted in accelerated tumor growth in the muscle and shortened the survival time of the mice, but these changes were blocked by an IL-1β neutralizing antibody (Fig. 6a).